Latest evidence-based view
IJJ · HOLD
IJJ (iShares S&P Mid-Cap 400 Value) tilts toward small and mid-sized companies that are more sensitive to growth and financing. One-month (-2.63%) and three-month (+1.76%) evidence is not decisive enough for a directional call.
IJJ currently supports a wait stance.
One-month (-2.63%) and three-month (+1.76%) evidence is not decisive enough for a directional call.
The opposing case is clear: Higher rates and tighter credit can magnify liquidity and funding risk. The 0.18% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.